Final Participating Company Line-Up Announced for the Virtual Investor Pitch Conference Hosted by JTC Team Being Held June 17 - 18, 2024
- Two-day conference with live video webcast presentations and Q&A beginning today, June 17th at 9:00 AM ET
- Full schedule of participating companies now available at www.virtualinvestorco.com
FRENCHTOWN, NJ / ACCESSWIRE / June 17, 2024 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced the final participating company line-up for the two-day Virtual Investor Pitch Conference beginning today, Monday, June 17, 2024.
For the event, participating companies will provide their "elevator pitch" and outline upcoming milestones. Additionally, investors and interested parties will have the opportunity to submit questions live during the event. Participating companies will answer as many questions as possible in the time allowed.
The final schedule of participating companies is as follows:
Monday, June 17
- 9:00 AM ET: Kaida BioPharma, Inc. (Private) - Webcast
- 10:00 AM ET: Adolore BioTherapeutics, Inc. (Private) - Webcast
- 12:00 PM ET: Palisade Bio, Inc. (NASDAQ:PALI) - Webcast
- 1:00 PM ET: AIM ImmunoTech Inc. (NYSE:AIM) - Webcast
- 4:00 PM ET: enVVeno Medical Corporation (NASDAQ:NVNO) - Webcast
Tuesday, June 18
- 10:00 AM ET: Royalty Management Holding Corporation (NASDAQ:RMCO) - Webcast
- 11:00 AM ET: GRI Bio, Inc. (NASDAQ:GRI) - Webcast
- 12:00 PM ET: Outlook Therapeutics, Inc. (NASDAQ:OTLK) - Webcast
- 1:00 PM ET: American Resources Corporation (NASDAQ:AREC) - Webcast
- 2:00 PM ET: Annovis Bio Inc. (NYSE:ANVS) - Webcast
- 3:00 PM ET: Moleculin Biotech, Inc. (NASDAQ:MBRX) - Webcast
All investors and interested parties can access the event schedule and individual company webcast details at www.virtualinvestorco.com. Webcast replays will be made available shortly after the conclusion of the live event and will be accessible for 90 days.
To access all Virtual Investor events, visit www.virtualinvestorco.com.
About JTC Team
JTC is a fully integrated investor relations firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit www.jtcir.com or connect with the company on X and LinkedIn.
Contact:
Jenene Thomas
JTC Team, LLC
T: +1 (833) 475-8247
[email protected]
SOURCE: JTC Team, LLC
View the original press release on accesswire.com